Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Placebo analgesia is a robust experimental and clinical phenomenon. While our understanding of the mechanisms of placebo analgesia has developed rapidly, some central questions remain unanswered. Among the important questions is how placebo anal-gesia interacts with active analgesic effects. It is an assumption underlying double-blind randomized placebo-controlled trials (RCTs) that the true effect of a treatment can be determined by examining the effect of the active treatment arm and subtracting the response in the placebo group (“the assumption of additivity”). However, despite the importance of this assumption for the interpretation of RCTs, it has rarely been formally examined. This article reviews the assumption of additivity in placebo analgesia by examining studies employing factorial designs manipulating both the receipt of an active analgesic and instructions about the treatment being delivered. In reviewing the literature, we identified seven studies that allowed a test of additivity. Of these, four found evidence against additivity, while the remaining three studies found results consistent with additivity. While the limited available data are somewhat mixed, the evidence suggests that at least under some conditions the assumption of additivity does not hold in placebo analgesia. The concordance between mechanisms of the active analgesic and placebo analgesia may influence whether additivity occurs or not. However, more research using factorial designs is needed to disentangle the relationship between placebo analgesia and the active effect of analgesic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Placebo and Opioid Analgesia-- Imaging a Shared Neuronal Network
Petrovic, P., Kalso, E., Petersson, K. M., & Ingvar, M. (2002) · Science · doi:10.1126/science.1067176 · Cited by 1,488
THE MECHANISM OF PLACEBO ANALGESIA
Levine, J., Gordon, N., & Fields, H. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92762-9 · Cited by 1,094
Amanzio, M., & Benedetti, F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-01-00484.1999 · Cited by 899
Bingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., & Tracey, I. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001244 · Cited by 810
Hare, T. A., O'Doherty, J., Camerer, C. F., Schultz, W., & Rangel, A. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1309-08.2008 · Cited by 792
Benedetti, F., Pollo, A., Lopiano, L., Lanotte, M., Vighetti, S., & Rainero, I. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04315.2003 · Cited by 788
Placebo Effects Mediated by Endogenous Opioid Activity on μ-Opioid Receptors
Zubieta, J.-K., Bueller, J. A., Jackson, L. R., Scott, D. J., Xu, Y., Koeppe, R. A., Nichols, T. E., & Stohler, C. S. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.0439-05.2005 · Cited by 779 · cited 3×
“Found in abundance throughout these regions are μ-opioid receptors (Baumgärtner et al., 2006; Wager, Scott, & Zubieta, 2007; Zubieta et al., 2005), which play a crucial role in inhibiting pain perception during placebo analgesia by influencing nociceptive processing at both the subcortical (Wager…”
BackgroundPlacebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
Placebo effects on human μ-opioid activity during pain
Wager, T. D., Scott, D. J., & Zubieta, J.-K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702413104 · Cited by 562 · cited 1×
“As previously discussed, research suggests that endogenous opioids are one of the primary systems by which the placebo effect inhibits pain (Levine et al., 1978; Wager et al., 2007; Zubieta et al., 2005), the same system on which opioid analgesics have their exogenous effect.”
BackgroundGetting the pain you expect: mechanisms of placebo, nocebo and reappraisal effects in humans
Tracey, I. (2010) · Nature Medicine · doi:10.1038/nm.2229 · Cited by 553 · cited 1×
“These higher order areas then engage a broad network of regions, notably the descending pain modulatory system which encompasses regions such as the rostral anterior cingulate cortex (ACC), amygdala, hypothalamus, and the periaqueductal grey (Bingel et al., 2011; Eippert et al., 2009; Tracey, 2010).”
BackgroundIndividual differences in reward responding explain placebo-induced expectations and effects
Scott, D. J., Stohler, C. S., Egnatuk, C. M., Wang, H., Koeppe, R. A., & Zubieta, J.-K. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.028 · Cited by 466 · cited 2×
“Both of these regions have also been implicated in prediction error processing (Carter et al., 1998; Hare, O’Doherty, Camerer, Schultz, & Rangel, 2008), a mechanism which has been previously suggested to play a role in the instigation of placebo analgesia (Petrovic et al., 2010; Scott et al., 2007).”
BackgroundPlacebos and painkillers: is mind as real as matter?
Colloca, L., & Benedetti, F. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1705 · Cited by 465 · cited 1×
“…mechanisms (Benedetti, 2008, 2009; Benedetti, Maggi, et al., 2003; Benedetti, Pollo, et al., 2003; Colagiuri, Schenk, Kessler, Dorsey, & Colloca, 2015; Colloca & Benedetti, 2005; Enck, Benedetti, & Schedlowski, 2008), as well as the degree of placebo effect itself (Hróbjartsson & Gøtzsche, 2010).”
Self-citationHow prior experience shapes placebo analgesia
Colloca, L., & Benedetti, F. (2006) · Pain · doi:10.1016/j.pain.2006.04.005 · Cited by 443 · cited 1×
“Recent models propose that placebo analgesia is the result of expectancies induced via the treatment context, such as the verbal, social, and contextual cues surrounding the treatment (Colagiuri et al., 2015; Colloca & Benedetti, 2006, 2009; Stewart-Williams & Podd, 2004).”
BackgroundSelf-citationResponse expectancies in placebo analgesia and their clinical relevance
Pollo, A., Amanzio, M., Arslanian, A., Casadio, C., Maggi, G., & Benedetti, F. (2001) · Pain · doi:10.1016/s0304-3959(01)00296-2 · Cited by 442 · cited 2×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Maggi, & Benedetti, 2001; Benedetti, Amanzio, & Maggi, 1995; Pollo et al., 2001), with the placebo effect also comprising part of the therapeutic effect of analgesics (Benedetti, Maggi, et al., 2003; Benedetti, Pollo,…”
BackgroundThe biochemical and neuroendocrine bases of the hyperalgesic nocebo effect
Benedetti, F., Amanzio, M., Vighetti, S., & Asteggiano, G. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.2947-06.2006 · Cited by 419
Placebo analgesia induced by social observational learning
Colloca, L., & Benedetti, F. (2009) · Pain · doi:10.1016/j.pain.2009.01.033 · Cited by 416
Self-citationAltered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks
Kam-Hansen, S., Jakubowski, M., Kelley, J. M., Kirsch, I., Hoaglin, D. C., Kaptchuk, T. J., & Burstein, R. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006175 · Cited by 399 · cited 13×
“…M anuscript A uthor M anuscript A uthor M anuscript The time course of the treatment relative to outcome assessment was reported in most studies and varied between 13.5 min and 4 h (Aslaksen et al., 2015; Atlas et al., 2012; Berna et al., 2017; Butcher & Carmody, 2012; Kam-Hansen et al., 2014).”
BackgroundMethodResultInfluentialPrefrontal cortex modulates placebo analgesia
Krummenacher, P., Candia, V., Folkers, G., Schedlowski, M., & Schönbächler, G. (2010) · Pain · doi:10.1016/j.pain.2009.09.033 · Cited by 337
Synergistic interactions between cannabinoid and opioid analgesics
Cichewicz, D. L. (2004) · Life Sciences · doi:10.1016/j.lfs.2003.09.038 · Cited by 305 · cited 1×
“…analgesics and may provide some evidence for superadditivity (Christie, Connor, Vaughan, Ingram, & Bagley, 2000; Christie, Vaughan, & Ingram, 1999; Cichewicz, 2004; Miranda, Silva, & Pinardi, 2004; Tallarida, 2001; Vaughan, Ingram, Connor, & Christie, 1997), in which the distinct mechanisms by…”
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors
Benedetti, F., Amanzio, M., Rosato, R., & Blanchard, C. (2011) · Nature Medicine · doi:10.1038/nm.2435 · Cited by 289 · cited 10×
“Understanding NSAIDs: From aspirin to COX-2.”
BackgroundInfluentialBlockade of nocebo hyperalgesia by the cholecystokinin antagonist proglumide
Benedetti, F., Amanzio, M., Casadio, C., Oliaro, A., & Maggi, G. (1997) · Pain · doi:10.1016/s0304-3959(97)03346-0 · Cited by 238
Partial antagonism of placebo analgesia by naloxone
Grevert, P., Albert, L. H., & Goldstein, A. (1983) · Pain · doi:10.1016/0304-3959(83)90203-8 · Cited by 228
Amanzio, M., Benedetti, F., Porro, C. A., Palermo, S., & Cauda, F. (2013) · Human Brain Mapping · doi:10.1002/hbm.21471 · Cited by 202 · cited 2×
“In contrast, knowledge of treatment administration was more closely related to activity in the PFC—one of the regions that is most commonly associated with placebo analgesia (Krummenacher, Candia, Folkers, Schedlowski, & Schönbächler, 2010; Petrovic et al., 2010).”
BackgroundBenedetti, F., Durando, J., & Vighetti, S. (2014) · Pain · doi:10.1016/j.pain.2014.01.016 · Cited by 109 · cited 2×
“…that these studies found that the placebo effect was either only effective in this manner after preconditioning (Benedetti et al., 2015) or in reducing the nocebo-provoked component of headaches (Benedetti et al., 2014), and so may not be a widely recruited mechanism for headaches generally.”
BackgroundRandomised controlled trials may underestimate drug effects: balanced placebo trial design
Lund, K., Vase, L., Petersen, G. L., Jensen, T. S., & Finnerup, N. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084104 · Cited by 72 · cited 18×
“Three studies examined lidocaine, a sodium channel blocker (Aslaksen et al., 2015; Lund et al., 2014; Schenk et al., 2014), two examined NSAIDs, namely diclofenac and ibuprofen (Berna et al., 2017; Butcher & Carmody, 2012), one examined maxalt, a triptan used to treat migraines (Kam-Hansen et al.,…”
BackgroundMethodResultInfluential
Cited by
Placebo 2.0: the impact of expectations on analgesic treatment outcome
Bingel, U. (2020) · Pain · doi:10.1097/j.pain.0000000000001981 · Cited by 113
How do they add up? The interaction between the placebo and treatment effect: A systematic review
Boussageon, R., Howick, J., Baron, R., Naudet, F., Falissard, B., Harika‐Germaneau, G., Wassouf, I., Gueyffier, F., Jaafari, N., & Blanchard, C. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15345 · Cited by 36
“In the case of antagonistic interaction, the total effect of a treatment is inferior to the sum total of the placebo effect and the specific effect of the treatment, whereas in the synergistic model the total effect of a treatment is superior to the sum total of the placebo effect and the specific effect.(6,12,18) In…”
BackgroundResultDavies, J. N., Sharpe, L., Day, M. A., & Colagiuri, B. (2022) · Pain · doi:10.1097/j.pain.0000000000002593 · Cited by 18
Mindfulness Effects on Anxiety: Disentangling the Role of Decentering and Treatment Expectations
Bos, D. P. A., Keesman, M., Roggeveen, A., Vase, L., Evers, A. W. M., & Peerdeman, K. J. (2024) · Behavior Therapy · doi:10.1016/j.beth.2024.03.004 · Cited by 5
Metadata
- Authors
- Coleshill, M. J., Sharpe, L., Colloca, L., Zachariae, R., & Colagiuri, B.
- Venue
- International Review of Neurobiology
- Publisher
- Elsevier
- Published
- 2018
- Volume
- 139
- Pages
- 407-441
- ISSN
- 0074-7742 (ISSN-L)
- OpenAlex
- W2887110406
- Cited by
- 25
- References
- 25
- FWCI
- 3.10
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.